| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.2 | 4e-09 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-08 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-08 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-07 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-07 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-07 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.16 | 8e-07 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-07 |